Open Access<p>Identification of Clinically Significant Prostate Cancer by Combined <em>PCA3</em> and <em>AMACR</em> mRNA Detection in Urine Samples</p>
Author(s) -
E. S. Kotova,
Yulia A. Savochkina,
Yuriy V Doludin,
A. O. Vasilyev,
Elena A Prilepskay,
Natalia V. Potoldykova,
Konstantin Babalyan,
Alexandra Kanygina,
Andrey Morozov,
Alexander Govorov,
Dmitry Enikeev,
Elena Kostryukova,
Elena Ilina,
Vadim Govorun,
Dmitry Pushkar,
Е. И. Шарова
Publication year - 2020
Publication title -
research and reports in urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.506
H-Index - 20
ISSN - 2253-2447
DOI - 10.2147/rru.s262310
Subject(s) - prostate cancer , medicine , pca3 , prostatectomy , urology , urine , prostate , cohort , prostate biopsy , area under the curve , prostate specific antigen , oncology , cancer , gynecology
Preclinical evaluation of PCA3 and AMACR transcript simultaneous detection in urine to diagnose clinical significant prostate cancer (prostate cancer with Gleason score ≥7) in a Russian cohort.